Cargando…
Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716993/ http://dx.doi.org/10.1186/1742-4690-3-S1-S8 |
| _version_ | 1782131381403385856 |
|---|---|
| author | Allaway, Graham P |
| author_facet | Allaway, Graham P |
| author_sort | Allaway, Graham P |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1716993 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-17169932006-12-23 Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor Allaway, Graham P Retrovirology Oral Presentation BioMed Central 2006-12-21 /pmc/articles/PMC1716993/ http://dx.doi.org/10.1186/1742-4690-3-S1-S8 Text en Copyright © 2006 Allaway; licensee BioMed Central Ltd. |
| spellingShingle | Oral Presentation Allaway, Graham P Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor |
| title | Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor |
| title_full | Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor |
| title_fullStr | Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor |
| title_full_unstemmed | Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor |
| title_short | Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor |
| title_sort | development of bevirimat (pa-457): first-in-class hiv maturation inhibitor |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716993/ http://dx.doi.org/10.1186/1742-4690-3-S1-S8 |
| work_keys_str_mv | AT allawaygrahamp developmentofbevirimatpa457firstinclasshivmaturationinhibitor |